Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.

Here's what the most common symptoms of celiac disease are, what causes it and how it is usually treated.

The federal budget reconciliation bill signed into law July 4 only reinforces and exacerbates the food insecurity that ...

A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), ...

Celiac disease, affecting 1% globally, often goes undiagnosed due to its varied symptoms beyond digestion. This autoimmune ...

SNY's SAR446597, a one-time intravitreal gene therapy, secures FDA fast track tag for geographic atrophy due to age-related macular degeneration.

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be predictive of disease progression.

A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study presented Monday at ENDO 2025, the Endocrine Society's annual ...